What is thyroid cancer?

The thyroid is a butterfly-shaped gland located at the front of our neck. Thyroid cancer, a malignant tumor that develops from the cells of the thyroid gland.

What types of thyroid cancer are classified

The World Health Organization (WHO) classifies thyroid cancer into four categories:

    Papillary carcinoma

  • Papillary thyroid carcinoma (PTC)
  • Papillary thyroid carcinoma (PTC)
  • follicular thyroid carcinoma (FTC)
  • Medullary thyroid cancer (MTC)
  • anaplastic thyroid cancer (ATC)

These four categories cover more than 95% of all thyroid cancers. Of these, papillary and follicular carcinomas are together called differentiated thyroid cancer.

Related reading:

Different types of thyroid cancer have different characteristics, as detailed in the table below

Table 1. Characteristics of the four major types of thyroid cancer

Type Percentage Population with good prevalence Clinical features Outcome
Papillary carcinoma About 80% 20 to 40 years old, more common in women There are usually no obvious symptoms in the early stages, but hoarseness and dyspnea may occur in the later stages Lower malignancy, 10-year survival rate of 90%, easy recurrence
Follicular carcinoma 10% to 15% around age 50 Usually asymptomatic nodules, which can present later with symptoms such as hoarseness and dyspnea Moderately malignant, the prognosis is not as good as for papillary carcinoma, with 10-year survival rates of 98%, 88%, and 56% for patients in the low-, intermediate-, and high-risk groups, respectively.
Medullary carcinoma of the thyroid 5% Any age, common between 50 and 60 years, similar proportion of men and women Neck lumps, facial flushing, palpitations, diarrhea, and wasting Moderate malignancy, with 10-year survival rates averaging 50% to 90%.
Undifferentiated carcinoma of the thyroid 5 % or so around 70 years old presenting with a rapidly growing mass in the neck with local compression symptoms such as dyspnea, dysphagia, hoarseness Highly malignant, with a one-year survival rate of 5% to 15%.

Recognizing rare thyroid cancers

In addition to the four common types mentioned above, thyroid cancer includes many rare types, and their characteristics are summarized in the table below.

Table 2. Characteristics of rare types of thyroid cancer

 type Population Clinical features Outcome
Hürthle cell carcinoma Female and over 50 years More aggressive and more likely to metastasize distantly Poorer
Primary squamous cell carcinoma of the thyroid

Elderly, more commonly in women

Tumor is rapidly enlarging, with significant signs of compression, and lymph node metastases may occur Highly malignant, aggressive, poor outcome, 5-year survival rate less than 50%
Mixed medullary-filtrating carcinoma of the thyroid

Similar to medullary carcinoma, occurring at any age and in similar proportions in men and women

Lymph node and distant metastases, along with elevated blood calcitonin levels Moderate malignancy with 10-year survival rates averaging over 50% to 90%
Primary mucinous epidermoid carcinoma of the thyroid Female Early presentation is mostly asymptomatic thyroid nodules, with corresponding presentation in later stages due to external invasion and compression. Low malignancy, with a 5-year survival rate of nearly 90%
Intra-thyroidal thymic carcinoma Middle-aged and elderly Longer, slower progressive disease, often presenting as a painless nodule followed by symptoms such as tracheal compression or hoarseness Better outcome
Sclerosing mucinous epidermoid carcinoma with eosinophilia Adults, more common in women Progressively enlarging neck mass with a tendency to extrathyroidal invasion About half of patients have a disease-free survival of 3 months to 9 years, and half have local recurrence or distant metastases
Primary mucinous thyroid cancer Unclear High incidence of lymph node metastasis, susceptible to distant metastases, and rapid progression Poor outcome

Note: Calcitonin (CT) is a common blood marker used to detect and follow up medullary carcinoma.

Co-written by Dr. Tingting Zhang, Cancer Hospital of Fudan University